Concepedia

A 24‐week study to evaluate the effect of rilapladib on cognition and cerebrospinal fluid biomarkers of Alzheimer's disease

Gareth Maher‐Edwards, Jeni De'Ath, Carly Barnett, Arseniy Lavrov, Andrew Lockhart

Alzheimer s & Dementia Translational Research & Clinical Interventions · 2015 · 50 citations · 21 references

DOIFull text

Open access

Abstract

Clinicaltrials.gov identifier: NCT01428453.

References

21

Clinical diagnosis of Alzheimer's disease

Guy M. McKhann, David A. Drachman, Marshall Folstein et al. · Neurology · 1984 · 27.8K citations · Full text

Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales

The Lancet · 2001 · 1.3K citations

, , +11

Blood–brain barrier: Ageing and microvascular disease – systematic review and meta-analysis

Andrew Farrall, Joanna M. Wardlaw · Neurobiology of Aging · 2007 · 870 citations

Blood brain barrier: ageing and microvascular disease-systematic review and meta-analysis

Andrew Farrall, Joanna M. Wardlaw · Journal of the Neurological Sciences · 2009 · 643 citations

, , +10

Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab

Martin Gunnarsson, Clas Malmeström, Markus Axelsson et al. · Annals of Neurology · 2010 · 337 citations · Full text